EY and BlackLine also reported a new strategic alliance. Equities Trading DOWN. Apricus Biosciences Inc (NASDAQ: APRI) shares dropped 63 percent to $1.18 after the nano-cap pharmaceutical company that focuses on products in the areas of urology and rheumatology announced a disappointing ...
more here
No comments:
Post a Comment